Involved-field (IF) Versus Extended-field (EF) Radiation Therapy (RT) for Patients in Early Unfavorable Stages of Hodgkin Lymphoma: 10-year Update of the HD8 Trial of the German Hodgkin Study Group (GHSG)

H.T Eich,J Kriz,B Klimm,S Sasse,H Görgen,V Diehl,P Borchmann,R Mueller,A Engert

doi:10.1016/j.ijrobp.2012.07.288

Involved-field (IF) Versus Extended-field (EF) Radiation Therapy (RT) for Patients in Early Unfavorable Stages of Hodgkin Lymphoma: 10-year Update of the HD8 Trial of the German Hodgkin Study Group (GHSG)

H.T Eich, J Kriz + Show 7 more

Open Access

https://doi.org/10.1016/j.ijrobp.2012.07.288

Copy DOI

Journal: International Journal of Radiation Oncology, Biology, Physics	Publication Date: Oct 25, 2012
Citations: 2

Affiliation: University of Cologne, University of Münster

#Freedom From Treatment Failure #German Hodgkin Study Group + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Combined modality treatment consisting of chemotherapy followed by RT has shown better results in respect to overall survival (OS), progression free survival (PFS) and freedom from treatment failure (FFTF) compared to RT alone for patients in early unfavorable stages of HL. The HD8 trial was designed to test whether IF-RT is as effective as EF-RT. The main aim was to reduce treatment related toxicity. The present analysis shows the 10-year follow-up data.

Full Text